Skip to main content
TipRanks
Go Ultimate75% OFF

ElevateBio, LLC Insider Profile

11 Followers

ElevateBio, LLC, Director, Ten Percent Owner at Kalaris Therapeutics, holds 16.67M shares in Kalaris Therapeutics (Ticker: KLRS).

ElevateBio, LLC's Trading History

KLRS
Kalaris Therapeutics
Aug 01, 2022Director, Ten Percent OwnerUninformative Buy15.00M$26.26M
KLRS
Insider Shares: 16.67M (25.49%)

ElevateBio, LLC has not reported any informative transactions for KLRS, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 01, 2022Uninformative Buy$15.00M3,253,796$4.61―
Aug 05, 2020Uninformative Buy$0.0013,420,970$0.00―

You May Also Like

ElevateBio, LLC insider profile FAQ

What stocks does ElevateBio, LLC hold?
ElevateBio, LLC holds: KLRS stocks.
What was ElevateBio, LLC’s latest transaction?
ElevateBio, LLC’s latest transaction was an Uninformative Buy of $15.00M.
What is ElevateBio, LLC's role in Kalaris Therapeutics?
ElevateBio, LLC's role in Kalaris Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.